Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henriette Berenschot

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[A woman with low hemoglobin values]Jurgen A Riedl, Henriette Berenschot
Haematologica|September 23, 2017
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase studyPieternella Lugtenburg, Irit Avivi, Henriette Berenschot, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[A woman with low hemoglobin values]Jurgen A Riedl, Henriette Berenschot
Haematologica|September 23, 2017
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase studyPieternella Lugtenburg, Irit Avivi, Henriette Berenschot, et al.
Pageof 1